Zepp Health Corporation (ZEPP)
| Previous close | 0.8400 |
| Open | 0.8310 |
| Bid | 0.8251 x 800 |
| Ask | 0.8750 x 800 |
| Day's range | 0.8260 - 0.8800 |
| 52-week range | 0.8200 - 2.1000 |
| Volume | |
| Avg. volume | 70,950 |
| Market cap | 51.882M |
| Beta (5Y monthly) | 0.85 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -0.6500 |
| Earnings date | 21 May 2024 - 27 May 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | 25 Mar 2022 |
| 1y target est | 4.96 |
PR NewswireZepp Health Corporation Files 2023 Annual Report on Form 20-F
Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today announced that it has filed its annual report on Form 20-F for the full year ended December 31, 2023 with the U.S. Securities and Exchange Commission (the "SEC").
PR NewswireZepp Health to Honor Marathon Icon Kelvin Kiptum with Amazfit Cheetah Pro Commemorative Edition Watch and Foundation Support
Zepp Health Corporation ("Zepp Health") (NYSE: ZEPP), a global leader in smart wearables and health technology, today announced its partnership with the Kelvin Kiptum Foundation, a significant initiative aimed at preserving the legacy of the late marathon world record holder Kelvin Kiptum, who tragically died in a car crash on February 11th, 2024. As part of this landmark partnership, Zepp Health, through its brand Amazfit, will donate $100,000 to the foundation, along with profits from sales of
PR NewswireZepp Health Corporation Reports Fourth Quarter and Full Year 2023 Unaudited Financial Results
Zepp Health Corporation ("Zepp" or the "Company") (NYSE: ZEPP) today reported revenues of US$84.5 million (RMB0.6 billion); a basic and diluted net loss per share of US$0.005 (RMB0.03); and a basic and diluted net loss per ADS of US$0.02 (RMB0.14) for the fourth quarter ended December 31, 2023; adjusted basic and diluted net income per share of US$0.002 (RMB0.01); and adjusted basic and diluted net income per ADS of US$0.01 (RMB0.06). Each ADS represents four Class A ordinary shares.
